Advanced Filters
noise
Found 64,783 clinical trials
Y Yuan Tan

Multi-modal Quantitative Imaging of the Skin

This clinical trial is about evaluating the suitability of multi-modal imaging technology, which covers virtually the entire body, to evaluate the possibility of screening and early detection of disease.

18 years of age All Phase N/A
M Mayank Mathur, MD

Vitaccess Real MG Registry

Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will be recruited in the …

18 years of age All Phase N/A
L Lei Xu, MD

Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population

The association between biological aging and type 2 diabetes mellitus (T2DM) incidence in individuals with and without metabolic dysfunction-associated steatotic liver disease (MASLD) remains unclear.We assessed biological age by calculating phenotypic age (PhenoAge), Klemera-Doubal method (KDMAge), and homeostatic dysregulation (HDAge). To examine the association of biological ageing with the risk …

20 - 90 years of age All Phase N/A
H Hyunil Jo, KMD

Safety and Efficacy of Integrative Korean Medicine Treatment for Elderly After Traffic Accident

The purpose of this study was to analyze the medical records of elderly traffic accident patients hospitalized at 4 branches of Jaseng Korean Medicine Hospital to determine the status of elderly patients and the effectiveness and safety of Korean medicine combination treatment.

65 years of age All Phase N/A
R Ros Eeles

The i4i PRODICT™ Study: Evaluation of the i4i PRODICT™ Test in Different Ethnic Groups (The i4i PRODICT™ Study).

The i4i PRODICT™ study has been developed to investigate the uptake and acceptability of the i4i PRODICT™ test which combines both common and rare genetic changes (genetic variants) into one saliva-based DNA test to estimate a person's future risk of prostate cancer (PrCa) in people of varying ethnicities.

40 - 55 years of age Male Phase N/A
I Ismail Turkbey

Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)

The purpose of this study is to develop a new way to diagnose prostate cancer through the use of artificial intelligence. The goal is for this new method to reduce delays in diagnoses and to avoid invasive procedures such as biopsies.

18 - 89 years of age Male Phase N/A
J Jeffrey Marshall, MD

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer

The purpose of this research study is to test a new process for diagnosing lung cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this study will …

18 years of age All Phase N/A

A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19

The purpose of this study is to look at the safety and effectiveness of PAXLOVID in the real world and not in clinical studies. The study observes patients who have a high chance of getting severe COVID-19 in Korea. This study is seeking participants who are: Patients with mild-to-moderate COVID-19 …

19 years of age All Phase N/A

A Postmarketing Study of Lecanemab in South Korean Participants With Alzheimer's Disease

The primary purpose of this study is to evaluate safety of lecanemab in the real-world clinical setting as reported by events of amyloid-related imaging abnormalities (ARIA)-edema (ARIA-E), ARIA-hemosiderin deposition (ARIA-H), symptomatic ARIA-E, symptomatic ARIA-H, and intracerebral hemorrhage (ICH) greater-than 1 centimeter (cm) in participants treated with lecanemab.

18 years of age All Phase N/A
S Soraya Fenniche, MD

Tunisian Lung Cancer Study

This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.

18 years of age All Phase N/A

Simplify language using AI